Laird Norton Wetherby Trust Company
GILD icon

Laird Norton Wetherby Trust Company’s Gilead Sciences GILD Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.59M Sell
44,230
-3,453
-7% -$455K 0.11% 144
2026
Q1 		$6.65M Buy
47,683
+4
+0% +$560 0.15% 106
2025
Q4 		$5.85M Buy
+47,679
New +$5.79M 0.12% 134

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Laird Norton Wetherby Trust Company's GILD Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its Gilead Sciences (GILD) stake by 7.2% in Q2 2026, selling an estimated $455K and leaving 44,230 shares worth $5.59M. The position accounts for 0.11% of the portfolio, ranked #144.

Laird Norton Wetherby Trust Company first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.65M in Q1 2026. 2,293 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 44,230 shares of Gilead Sciences worth $5.59M as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 3,453 Gilead Sciences shares in Q2 2026, an estimated $455K.
  • Gilead Sciences made up 0.11% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #144 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Laird Norton Wetherby Trust Company's Gilead Sciences position peaked at $6.65M in Q1 2026.
  • 2,293 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.